97 related articles for article (PubMed ID: 27301426)
1. Interaction of tRNA with MEK2 in pancreatic cancer cells.
Wang X; Chow CR; Ebine K; Lee J; Rosner MR; Pan T; Munshi HG
Sci Rep; 2016 Jun; 6():28260. PubMed ID: 27301426
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Kamohara H; Ishikawa S; Kurizaki T; Yoshida N; Tamori Y; Takai E; Hirota M; Ogawa M
Int J Oncol; 2004 Jan; 24(1):65-73. PubMed ID: 14654942
[TBL] [Abstract][Full Text] [Related]
3. MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells.
Zhou L; Tan X; Kamohara H; Wang W; Wang B; Liu J; Egami H; Baba H; Dai X
Oncol Rep; 2010 Jul; 24(1):251-5. PubMed ID: 20514469
[TBL] [Abstract][Full Text] [Related]
4. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
5. Arrangement of expression and distribution of tight junction protein claudin-1 in cell dissociation of pancreatic cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Nakagawa M; Hirota M; Ogawa M
Int J Oncol; 2004 Dec; 25(6):1567-74. PubMed ID: 15547692
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
7. Activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish.
Chou CM; Chen YC; Su S; Chen GD; Huang KY; Lien HW; Huang CJ; Cheng CH
J Biomed Sci; 2015 Nov; 22():102. PubMed ID: 26572230
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Tamori Y; Takai E; Hirota M; Ogawa M
Int J Oncol; 2004 Apr; 24(4):815-20. PubMed ID: 15010817
[TBL] [Abstract][Full Text] [Related]
9. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
10. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
Lee CS; Dykema KJ; Hawkins DM; Cherba DM; Webb CP; Furge KA; Duesbery NS
PLoS One; 2011 Feb; 6(2):e17165. PubMed ID: 21365009
[TBL] [Abstract][Full Text] [Related]
11. A full-length 3D structure for MAPK/ERK kinase 2 (MEK2).
Liang H; Liu T; Chen F; Liu Z; Liu S
Sci China Life Sci; 2011 Apr; 54(4):336-41. PubMed ID: 21509657
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
16. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.
Ohren JF; Chen H; Pavlovsky A; Whitehead C; Zhang E; Kuffa P; Yan C; McConnell P; Spessard C; Banotai C; Mueller WT; Delaney A; Omer C; Sebolt-Leopold J; Dudley DT; Leung IK; Flamme C; Warmus J; Kaufman M; Barrett S; Tecle H; Hasemann CA
Nat Struct Mol Biol; 2004 Dec; 11(12):1192-7. PubMed ID: 15543157
[TBL] [Abstract][Full Text] [Related]
17. Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect.
Aoidi R; Maltais A; Charron J
Sci Signal; 2016 Jan; 9(412):ra9. PubMed ID: 26814233
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
[TBL] [Abstract][Full Text] [Related]
19. MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response.
Kocieniewski P; Lipniacki T
Phys Biol; 2013 Jun; 10(3):035006. PubMed ID: 23735655
[TBL] [Abstract][Full Text] [Related]
20. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.
Smutny T; Bitman M; Urban M; Dubecka M; Vrzal R; Dvorak Z; Pavek P
Arch Toxicol; 2014 Dec; 88(12):2243-59. PubMed ID: 24819614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
